Products

Home >> NEWS

Forging New Frontiers: Healthdream Biotech Teams Up with AIDP and Top Universities to Advance Wellness Innovation

2026-05-20 11:17:53

A Strategic Step Forward in Global-Local Synergy

In a significant stride for biotechnology innovation, Healthdream Biotech recently joined forces with our long-standing international partner, AIDP Inc. (USA), to host a series of high-level research symposiums with two prestigious local 985 universities. This landmark collaboration marks a pivotal advancement in our corporate strategy of "Global Partnerships, Local Cultivation," setting a new benchmark for bridging fundamental research with industrial excellence.

Charting the Course: Three Pillars of R&D Excellence

During the intensive workshops, our team and the university experts defined a clear roadmap centered around three core experimental directions. This focused approach is designed to systematically enhance the core technical competitiveness of our products:
We firmly believe that by combining the universities' profound capabilities in basic research with our robust strengths in industrialization, quality control, and OEM services, we can effectively overcome critical technical barriers and accelerate the journey from lab discovery to market reality.

Deep Dive into Cutting-Edge Science

The symposiums were highlighted by fascinating exchanges of frontier science and tangible pathways for collaboration.
At one leading university, a distinguished PhD supervisor presented groundbreaking research on "Synthesis of High-Value Products via Microbial Cell Factories."​ This exploration into synthetic biology and metabolic engineering aims to create high-efficiency production pathways for valuable nutraceuticals. Following a tour of their state-of-the-art fermentation labs, both parties reached a consensus on collaborating in process optimization and mechanistic analysis, laying the groundwork for the next generation of high-performance probiotic strains.
Representatives from the second university showcased a series of translatable achievements centered on Medicinal and Edible Homologous (MEH)​ ingredients. Their presentations featured innovative studies on Polygonatum sibiricum peptides​ and Konjac Glucomannan, components that align perfectly with our mission to harness nature's power. Extensive discussions led to a mutual intent to establish joint R&D initiatives and share experimental platforms, paving the way for the commercialization of these potent natural extracts.

Our Commitment: Openness, Rigor, and Shared Success

This proactive move to unite the strengths of our international ally, AIDP, with top-tier local academic resources, underscores Healthdream Biotech's unwavering commitment to deepening our roots in biotechnology and pioneering research innovation. It is a testament to our belief that the future of wellness lies at the intersection of global vision and local scientific excellence.

Looking ahead, we will continue to uphold our core philosophy of "Openness, Rigor, and Win-Win."​ We are dedicated to fostering more substantive breakthroughs in key technological domains and cultivating a new generation of interdisciplinary talent. Through these efforts, Healthdream Biotech will continue to deliver high-quality, science-backed health solutions to the world, empowering a healthier future for all.